F.Y. 2019-20 - Independent Auditor's Report
F.Y. 2019-20 - Independent Auditor's Report
F.Y. 2019-20 - Independent Auditor's Report
REGISTERED OFFICE
AUDITORS
B. K. PATEL & CO
CHARTERED ACCOUNTANTS
OPINION
We have audited the accompanying standalone financial statements of Praveg Communications (India)
Limited (formerly known as Sword and Shield Pharma Limited in which Praveg Communications Limited
has been amalgamated) ("the Company"), which comprise the Balance Sheet as at March 31, 2020, the
Statement of Profit and Loss (including Other Comprehensive Income), the Statement of Changes in Equity
and the Statement of Cash Flows for the year ended on that date, and a summary of the significant
accounting policies and other explanatory information (hereina~er collec.:tively rererred to as "the
standalone financia l statements").
In our opinion and to the best of our information and according to the explanations given to us, the
aforesaidstandalone financial statements give the information required by the Com panies Ac.:t,
2013 ("the Act") in the manner so required and give a true and fair view in conformity with the India n
Accounting Standards prescribed under section 133 of the Act read with the Companies (In d ian
Accounting Standards) Rules, 2015 and other accounting principles generally accepted in India, of the
state of affairs of the Company as at March 31, 2020, the profit and tota l comprehensive income, changes
in equity and its cash flows for the year ended on that date.
We conducted our audit of the standalone financia l statements in accordance with lhe Standards on
Auditing specified under section 143(10) of the Companies Act, 2013 (SAs). Our responsibilities under
those Standards are further described in the Auditor's Responsibi lities for the Audit of the Standalone
Financial Statements section of our report.
We are independent of the Company in accordance with the Code of Ethics issued by the Institute of
Chartered Accountants of India (!CAI) together with the independence requirements that are relevant to
our audit of the standalone financial statements under the provisions of the Act and the Rules made
thereunder, and we have fu lfilled our other ethical responsibilities in accordance with these requirements
and the !CAi's Code of Ethics. We believe that the audit evidence we have obtained is s ufficient and
appropriate to provide a basis for our audit opinion on the standalone financi al statements.
EMPHASIS OF MATTER
1. We draw attention to Note No.41 to the accompanying standalone financial statements which
explains the uncertainties and the management's assessment of the financial impact due to the
lockdown and other restrictions related to the COVI0-19 pandemic situation, for which a definitive
1
assessment of the impact in the subsequent period is highly dependent upon circumstances as they
evolve. Our opinion is not modified in respect of the matter.
2. We draw attention to Note No.40to the accompanying standalone financial statements regarding
accounting of the scheme of amalgamation of Praveg Communications Limited in Praveg
Communications (India) Limited from the appointed date being 1st April, 2016 as approved by the
National Company Law Tribunal (NCLT), Ahmedabad Bench, though the Scheme has become
operationally effective fromlstMarch, 2020,however comparatives for the previous year have been
disclosed in the financial statements of both companies.
We have fulfil led the responsibilities descri bed in the Auditor's res ponsibilities for the audit of the
standalone financial statements section of our report, including in relation to these matters.
Accordingly, our audit included the performance of procedures designed to respond to our
assessment of the risks of material misstatement of the standalone financial statements. The results
of our audit procedures, including the procedures performed to address the matters below, provide
the basis for our audit opinion on the accompanying standalone fi nancial statements;
1) Accuracy of recognition, m easurement, presentation a nd disclos ures of revenues a nd othe r
related ba la nces in vie w oflnd AS 115 "Revenue from Contra cts w ith Customers":-
Matte r:-
The application of the Ind ASllS for revenue recognition involves certain key judgements such as
identification of distinct performance obligations, determination of transaction price of the
identified performance obligations, the appropriateness of the basis used to measure revenue
recognized over a period.
We assess the company's process to identify distinct performance obligations. transaction price
and appropriateness of the basis used to measure revenue recognized. Our audit approach
consisted testing of the design and operating effectiveness of the internal controls and substantive
testing as follows:
We evaluated the design of internal controls relating to revenue recognition. In the process, we
selected samples of continuing and new contracts, and tested the operating effectiveness of the
internal control, relating to ident ification of the distinct performance obligations and
determination of transaction price& basis of measurement We carried out a combination of
procedures involving enquiry and observation, re-performance and inspection of evidence in
respect of operation of these controls.
Selected a sample of continuing and new contracts and performed the following procedures:
Read, analysed and identified the distinct performance obligations in these contracts.
Compared these performance obligations with that identified and recorded by the Company.
Sample of revenues disaggregated by type and service offerings was tested with
theperformance obligations specified in the underlying contracts.
2
Evaluated the contracts on the basis of whether the contract is Fixed Price or Variable price
contract, terms of obligation fulfilment, duration of contract and accrual points of revenue
from such contracts.
We have determined this to be a key audit matter in view of the nature of transaction, complexity
involved in selection of accounting treatment for merger, significant management judgment
involved with respect to alignment of accounting policies, estimates and accounting post-merger
and disclosure of comparative information.
On verification of the Order of Hon'ble NCLT, Scheme approved by Hon'ble NCLT, standards of
accounting for treatment of business combinations i.e. Ind AS 103 and requirements of other
accounting standards with respect to business combinations read with Companies (Indian
Accounting Standards) Rules, 2015, the conclusion of management that the accounting treatment
of the amalgamation shall be given as per the specific directions under the scheme approved by
the Hon'ble NCLT and accounting treatment of the amalgamation shall be as per pooling of
interest method as directed by the scheme approved by Hon'ble NCLT found appropriate.
We have corroborated the adherence to the directions as mentioned in the Scheme approved by
Hon'ble NCLT in the management's alignment of accounting policies and estimates by comparing
the significant accounting policies and estimates.
Our opinion on the financial statements does not cover the other information and we will not
express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other
information identified above when it becomes available and, in doing so, consider whether the
other information is materially inconsistent with the financial statements or our
knowledgeobtained in the audit, or otherwise appears to be materially misstated.
The other information is expected to be made available to us after the date of this auditor's report.
When we read the other information, if we conclude that there is a material misstatement therein,
MANAGEMENT'S RESPONSIBILITY FOR THE STANDALONE FINANCIAL STATEMENTS
The Company's Board of Directors is responsible for the matters stated in section 134(5) of the Act
with respect to the preparation of these standalone financial statements that give a true and fair
view of the financial position, financial performance, total comprehensive income, changes in equity
and cash flows of the Company in accordance with the Ind AS and other accounting principles
generally accepted in India, This responsibility also includes maintenance of adequate accounting
records in accordance with the provisions of the Act for safeguarding the assets of the Company
and for preventing and detecting frauds and other irregularities; selection and application of
appropriate accounting policies; making judgments and estimates that are reasonable and prudent;
and design, implementation and maintenance of adequate internal financial controls, that were
operating effectively for ensuring the accuracy and completeness of the accounting records,
relevant to the preparation and presentation of the standalone financial statements that give a true
and fair view and are free from material misstatement, whether due to fraud or error.
In preparing the standalone financial statements, management is responsible for assessing the
Company's ability to continue as a going concern, disclosing, as applicable, matters related to going
concern and using the going concern basis of accounting unless management either intends to
liquidate the Company or to cease operations, or has no realistic alternative but to do so.
The Board of Directors a re responsible for overseeing the Company's financial reporting process.
As part of an audit in accordance with SAs, we exercise professional judgment and maintain
professional skepticism throughout the audit. We also :
•!• Identify and assess the risks of material misstatement of the standalone financial statements,
whether due to fraud or error, design and perform audit procedures responsive to those risks,
and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion.
The risk of not detecting a material misstatement resulting from fraud is higher than for one
resulting from error, as fraud may involve collusion, forgery, intentional omissions,
misrepresentations, or the override of internal controls.
•!• Obtain an understanding of internal financial controls relevant to the audit in order to design
audit procedures that are appropriate in the circumstances. Under section 143 (3) (i) of the Act.
we are also responsible for expressing our opinion on whether the Company has adequate
internal financial controls system in place and the operating effectiveness of such controls.
•!• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting
estimates and related disclosures made by management.
•!• Conclude on the appropriateness of management's use of the going concern basis of accounting
and, based on the audit evidence obtained, whether a material uncertainty exists related to
or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the
audit evidence obtained up to the date of our auditor's However, future events or conditions
may cause the Company to cease to continue as a going concern.
•!• Evaluate the overall presentation, structure and content of the standalone financial statements,
including the disclosures, and whether the standalone financial statements represent the
underlying transactions and events in a manner that achieves fair presentation.
•:• Materiality is the magnitude of misstatements in the standalone financial statements that,
individually or in aggregate, makes it probable that the economic decisions of a reasonably
knowledgeable user of the financial statements may be influenced. We consider quantitative
materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating
the results of our work; and (ii) to evaluate the effect of any identified misstatements in the
financial statements.
We communicated with those charged with governance regarding, among other matters, the
planned scope and timing of the audit and significant audit findings, including any significant
deficiencies in internal control that we identify during our audit
We also provided those charged with governance with a statement that we have complied with
relevant ethical requirements regarding independence, and to communicate with them all
relationships and other matters that may reasonably be thought to bear on our independence,
and where applicable, related safeguards.
From the matters communicated with those charged with governance, we determine those
matters that were of most significance in the audit of the standalone financial statements of the
current period and are therefore the key audit matters. We describe these matters in our
auditor's report unless law or regulation precludes public disclosure about the matter or when,
in extremely rare circumstances, we determine that a matter should not be communicated in
our report because the adverse consequences of doing so would reasonably be expected to
outweigh the public interest benefits of such communication.
a) We have sought and obtained all the information and explanations which to the best of our
knowledge and belief were necessary for the purposes of our audit
b) Jn our opinion, proper books of account as required by law have been kept by the Company so
far as it appears from our examination of those books.
c) The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income,
Statement of Changes in Equity and the Statement of Cash Flow dealt with by this Report are in
agreement with the relevant books of account.
d) In our opinion, the aforesaid standalone financial statements comply with the Ind AS specified
under Section 133 of the Act, read with Companies (Indian Accounting Standards) Rules, 2015,
as amended;
e) On the basis of the written representations received from the directors as on March 31, 2020
taken on record by the Board of Directors, none of the directors is disqualified as on March 31,
2020 from being appointed as a director in terms of Section 164 (2) of the Act
f) With respect to the adequacy of the internal financial controls over financial reporting of the
Company and the operating effectiveness of such controls, refer to our separate Report in
"Annexure- A". Our report expresses an unmodified opinion on the adequacy and operating
effectiveness of the Company's internal financial controls over financial reporting.
5
g) With respect to the other matters to be included in the Auditor's Report in accordance with the
requirements of section 197(16) of the Act, as amended:
In our opinion and to the best of our information and according to the explanations given to
us, the remuneration paid by the Company to its directors during the year is in accordance
with the provisions of section 197 of Lhe Act.
h) With respect to the other matters to be included in the Auditor's Report in accordance with
Rule 11 of the Companies (Audit and Auditors) Rules, 2014, as amended, in our opinion and to
the best of our information and according to the explanations given to us:
i) As informed to us. the Company has disclosed the impact of pending litigations on its
financial position in its standalone financial statements;
ii) The Company did not have any long-term contracts including derivative contracts for
which there were any material foreseeable losses;
iii) There has been no amount required to be transferred to the Investor Education and
Protection Fund by the Company.
2. As required by the Companies (Auditor's Report) Order, 2016 ("the Order") issued by the Central
Government in terms of Section 143(11) of the Act, we give in "Annexure-8" a s tatement on the
matters specified in paragraphs 3 and 4 of the Order.
..
er
Ahmedabad Membership No.039 19
3-7-2020 UDIN:20039919AAAABA9 77
6
ANNEXURE-"A" TO THE INDEPENDENT AUDITOR'S REPORT
(Referred to in paragraph l(f) under 'Report on Other Legal and Regulatory Requirements' section
of our report to the Members of Praveg Communications (India) Limited (formerly known as Sword
and Shield Pharma Limited) of even date)
REPORT ON THE INTERNAL FINANCIAL CONTROLS OVER FINANCIAL REPORTING UNDER CLAUSE
(I) OF SUB-SECTION 3 OF SECTION 143 OF THE COMPANIES ACT, 2013 ("THE ACT")
We have audited the internal financial controls over financial reporting of Praveg Communications
(India) Limited (formerly known as Sword and Shield Pharma Limited) ("the Company") as of
March 31, 2020 in conjunction with our audit of the standalone financial statements of the
Company for the year ended on that date.
AUDITOR'S RESPONSIBILITY
Our responsibility is to express an opinion on the internal financial controls over financial reporting
of the Company based on our audit We conducted our audit in accordance with the Guidance Note
on Audit of Internal Financial Controls Over Financial Reporting (the "Guidance Note") issued by
the Institute of Chartered Accountants of India and the Standards on Auditing prescribed under
Section 143(10) of the Companies Act, 2013, to the extent applicable to an audit of internal financial
controls. Those Standards and the Guidance Note require that we comply with ethical requirements
and plan and perform the audit to obtain reasonable assurance about whether adequate internal
financial controls over financial reporting was established and maintained and if such controls
operated effectively in all material respects.
Our audit involves performing procedures to obtain audit evidence about the adequacy of the
internal financial controls system over financial reporting and their operating effectiveness. Our
audit of internal financial controls over financial reporting included obtaining an understanding of
internal financial controls over financial reporting, assessing the risk that a material weakness
exists, and testing and evaluating the design and operating effectiveness of internal control based
on the assessed risk. The procedures selected depend on the auditor's judgement, including the
assessment of the risks of material misstatement of the financial statements, whether due to fraud
or error.
We believe that the audit evidence we have obtained, is sufficient and appropriate to provide a
basis for our audit opinion on the internal financial controls system over financial reporting of
the Company.
(Referred to in paragraph 2 under 'Report on Other Legal and Regulatory Requirements' section of our
report to the Members of Praveg Communications (India) Limited (Formerly Sword and Shield Pharma
Limited) of even date)
a) The Company has maintained proper records showing fu ll particulars, including quantitative
details and situation of fixed assets.
b) The Company has a program of verification to cover all the items of fixed assets, in our
opinion, is reasonable having regard to the size of the Company and the nature of its assets.
Pursuant to the program, fixed assets were physicaJJy verified by the management during the
year. According to the information and explanations given to us, no material discrepancies
were noticed on such verification.
c) According to the information and explanations given to us, the records examined by us and
based on the examination of the conveyance deeds / registered sale deed provided to us, we
report that, the title deeds, comprising a ll the immovable properties of land and buildings
which are freehold, are in the process to be transfer red to be held in the name of the Company
as at the balance sheet date. Company has already made application to superintendent of
stamp for stamp duty adjudications, the said application is under process. In respect of
immovable properties of land and building that have been taken on lease and disclosed as
fixed assets in the sta ndalone financial statements, the lease agreeme nts are in the process to
be transferred into name of the Company.
ii. As explained by the management, it has conducted physical verification of inventory at reasonable
intervals during the year and no material discrepancies were noticed on such physical verification.
iii. According the information and explanations given to us, the Company has granted unsecured loans
to its wholly owned subsidiary Company covered in the register maintained under section 189 of the
Companies J\ct, 2013, in respect of which:
(a) The terms and conditions of the grant of such Joans are, in our opinion, prima facie, not
prejudicial to the Company's interest
(b) The schedule of repayment of principal and payment of interest has been stipulated and
repayments or receipts of principal amounts and interest have been regular as per stipulations
(c) There is no overdue amount in respect of this loan remaining outstanding as at the year-end.
iv. In our opinion and according to the information and explanations given to us, the Company has
complied witl1 the provisions of Sections 185 and 186 of the Act in respect of grant of loans, making
investments and providing guarantees and securities, as applicable.
v. The Company has not accepted deposits during the year and does not have any unclaimed deposits
as at Ma rch 31, 2020 a nd therefore, the provisions of the clause 3 (v) of the Order are not applicable to
the Company.
vi. The maintenance of cost records has not been specified by the Central Government under section
148(1) of the Companies Act 2013 for the business activities carried out by the Company.Accordingly
repo rting under clause 3(vi) of the order is not applicable to the Company.
vii. According to the information and explanations given to us, in respect of statutory dues ;
The Company has generally been regular in depositing undisputed statutory dues, including
a)
Provident Fund, Employees' State Insurance, Income Tax, Goods and Service Tax, Customs
Duty, Cess and other material statutory dues as applicable to it with the appropriate
authorities. The provisions relating to excise duty are not applicable to the Company.
b) There were no undisputed amounts payable in respect of Provident Fund, Employees' State
____ Insurance, Income Tax, Goods and Service Tax, Customs Duty, Cess and other material
'B
'?j).lci.~~ 9
:·AH' u~
~ jg
11s 4P
PRAVEG COMMUNICATI ONS (INDIA) LIM ITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
CIN : L24231GJ1995PLC024809
Standa lone Balance Sheet as at 31- March-2020
Amount fn Rs. m Lokhs
As at As at
Particulars Note No.
31-Mar-2020 31-Mar-2019
1 Assets
1 Non-current Assets
(a) Property, Plant and Equipment 2 325.00 285.71
(b) Other Intangible Assets 2 0.30 0.36
(c) Financial Assets
(i) Non Current Investment 3 21.17 3.08
(d) Deferred Tax Assets (Net) 4 16.22 16.01
(e) Other Non Current Assets 5 6.95 8.24
2 Current Assets
(a) Inventories 6 244.28 195.76
(b) Financial Assets
(i) Trade Receivables 7 1,292.67 782.47
(ii) Cash and Cash Equivalents 8 252.22 95.55
(iii) Other Bank Balance 9 30.16 103.53
(iv) Current Loans 10 124.04 549.20
(v) Other Financial Assets 11 56.57 18.78
(c) Other Current Assets 12 109.18 129.60
1 Equity
(a) Equity Share Capital 13 1,848.41 1,848.41
(b) Other Equity 14 (359.58) (674.32)
2 Liabilities
2A Non-current Liabi lities
(a) Financial Liabilities
(i) Non-current Borrowings 15 91.83 95.29
113.83 95.29
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SH IELD PHARMA LIM ITED)
CIN : L24231GJ1995PLC024809
Standalone Balance Sheet as at 31-March-2020
Amount In Rs. In Lokhs
As at As at
Particulars Note No.
31-Mar-2020 31-Mar-2019
2B Current Liabilities
(a) Financial Liabilities
(i) Current Borrowings 17 3.48 416.32
(ii) Trade Payables
Total outstanding dues of creditors other
18 512.94 303.88
than micro and small enterprises
(iii) Other Financial Liabilities 19 93.93 48.20
(b) Current tax liabilities (net) 20 44.21 5.87
(c) Short Term Provisions 21 44.12 45.75
(d) Other Current Liabilities 22 177.42 98.89
R-J,tA
Paraskumar Patel
Managing Director
DIN :- 00467608
~~ Chairman
DIN :- 02011649
~
Chief Financial Officer
~~er
Mukesh Chaudhary
Company Secretary
CIN : l24231GJ1995PLC024809
Standa lone Statement of Profit and Loss for the year ended on 31-3-2020
Amount in Rs. In Lakhs
Expenses
Event & Site Expenses 25 4,277.49 4,469.46
Employee Benefit Expenses 26 432.01 350.40
Finance Costs 27 54.01 38.43
Depreciation and Amortisation Expense 2 96.72 40.00
Other Expenses 28 606.05 685.48
See accompanying notes to the financial statements For and on behalf of Board of Dlrectors
PRAVEG COMMUNICATIONS (INDIA) LIMITED
As per our report of even date (Formerly Known as Sword and Shield Pharma Limited)
For, 8. K. PATEL & CO. CIN : L24231GJ1995PLC024809
Chartered Accountants
-
t.~.,
(
~~
FRN :- 112647W
Paraskumar Patel
Managing Director Chairman
DIN :- 00467608 DIN :- 02011649
Membersh p No.039919
~ Q~
Mukesh Chaudhary
Chief Financial Officer Company Secre tary
B. Other equity
Amount in Rs. In Lokhs
Share Premium
Particulars Retained Earnings General Reserve Capital Reserve Total
Reserve
Balance as at 1-4-2018 (495.94) 0.00 0.00 0.00 (495.94)
Additions pursuant to the
scheme of arrangement 767.57 57.77 169.56 (1,315.57) (320.67)
during the year
Profit for the year 286.42 0.00 0.00 0.00 286.42
Dividend Paid (10.14) 0.00 0.00 0.00 (10.14)
Dividend Distribution Tax (2.06) 0.00 0.00 0.00 (2.06)
Utilised for buy back 0.00 0.00 (13 1.93) 0.00 (131.93)
Balance as at 31-3-2019 545.85 57.77 37.63 (1,315.57) (674.32)
Paraskumar Patel
Managing Director
~,.: Chairman
DIN :- 00467608 DIN :- 02011649
156.67 75.84
0.00 8.83
95.55 10.88
252.22 95.55
PRAVEG COMMUNICATIONS {INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
Standalone Statement of Cash Flow for the year ended 31-3-2020
i) The above Standalone Statement of Cash Flows has been prepared under the "Indirect Method" as set out in Indian Accounting
Standard (Ind AS) - 7 "Statement of Cash Flows" .
ii) Cash and cash equivalents comprise of: Amount In Rs. In Lokhs
As at As at
Particulars
31-Mar-2020 31-Mar-2019
Balances with banks: -
-In current accounts 29.11 90.91
-In Over Draft account 217.33 0.00
Cash on hand 5.78 4.64
Cash and cash equivalents as per statement of cash flow 252.22 95.55
Other
Particulars 1-4-2019 Cash flow 31-3-2020
Adjustment
Long-term Borrowings
(including Current Maturities of Long 143.49 42.27 0.00 185.76
Term Debt)
Short-term borrowing 416.32 (195.51) 0.00 220.81
Finance Cost Paid 0.00 (54.01) 0.00 (54.01)
Total 559.81 (207.25) 0.00 352.56
Other
Particulars 1-4-2018 Cash flow 31-3-2019
Adjustment
Long-term Borrowings
(including Current Maturities of Long 60.41 83.08 0.00 143.49
Term Debt)
Short-term borrowing 252.50 163.82 0.00 416.32
Finance Cost Paid 0.00 (38.43) 0.00 (38.43)
Pacas&J.*
Managing Director
c\i~~P~el Chairman
DIN :- 00467608 DIN :- 02011649
~·~'1>()
A&
CA Vira l Doshi
Chief Financial Officer
~~
Mukesh Chaudhary
Company Secretary
These statements comprise the Standalone Financial Information of Praveg Communications (India) Limited (the Company). The
Company is domiciled ln India, incorporated on February 28, 1995 under the provisions of the Companies Act applicable in India
and listed on Bombay Stock Exchange. The registered office of the company ls located at Shop No. 101, First Floor, Shanti Arcade,
132 Feet Ring Road, Naranpura Ahmedabad, Gujarat, PIN : 380 013, India.
The Company is principally engaged in business of providing services in holding and arranging Events, Exhibitions, Advertisement,
Hospitality and in pharma sector.
Ii Basis of measurement
The Standalone Financial Information has been prepared on a historical cost basis, except for the following:
- certain financial assets and liabilities that are measured at fair value (refer- Accounting policy regarding financials
instruments);
- defined benefit plans - plan assets measured at fair value less present value of defined benefit obligation; and
Historical cost is generally based on the fair value of the consideration given in exchange for goods and services. Accounting
policies have been consistently applied except where a newly Issued accounting standard is initially adopted or a revision to an
existing accounting standard requires a change in the accounting policy hitherto in use.
iii Presentation
Items included in the financial statements of the entity are measured using the currency of the primary economic environment in
which the entity operates ('the functional currency'). The financia l statements are presented in Indian rupee (INR) rounded off to
the nearest lakhs, except expressly stated otherwise, which Is entity's functional and presentation currency.
Each part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is
depreciated separately. When significant parts of plant and equipment are required to be replaced at intervals, the Company
d~r.ec~ them separately based on their specific useful lives. Likewise, when a major inspection is performed, its cost is
~~~
~ recog~c[.\ the carrying amount of the plant and equipment as a replacement if the recognition criteria are satisfied. All other
* ( (epa· nd m~ntenance costs are recognized in profit or loss as incurred.
q l
PRAVEG COMMUNICATlONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIM ITED)
CIN : L24231GJ199SPLC024809
Subsequent expenditure related to an item of property, plant and equipment is added to its book value only if it increases the
future benefits from its previously assessed standard of performance. All other expenses on existing property, plant and
equipment, including day-to-day repair and maintenance expenditure and cost of replacing parts, are charged to the statement of
profit and loss for the period during which such expenses are incurred.
Borrowing costs directly attributable to acquisition of property, plant and equipment which take substantial period of time to get
ready for its intended use are also included to the extent they relate to the period till such assets are ready to be put to use.
Advances paid towards the acquisition of property, plant and equipment outstanding at each balance sheet date is classified as
capital advances under other non-current assets.
An item of property, plant and equipment and any significant part initially recognized is de-recognized upon disposal or when no
future economic benefits are expected from its use or disposal. Any gain or loss arising on de-recognition of the asset (calculated
as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of profit
and loss when the Property, plant and equipment is de-recognized.
Expenditure directly relating to construction activity is capitalized. Indirect expenditure incurred during construction period is
capitalized to the extent to which the expenditure is indirectly related to construction or is incidental thereto. Other indirect
expenditure (including borrowing costs) incurred during the construction period which is neither related to the construction
activity nor is lncldental thereto is charged to the statement of profit and loss.
Costs of assets not ready for use at the balance sheet date are disclosed under capital work- in- progress.
The property, plant and equipment acquired under finance lease~ 1s depreciated over the asset's useful life or over the shorter of
the asset's useful life and the lease term If there is no reasonable certainty that the company will obtain ownership at the end of
the lease term. Leasehold land is amortised on a straighL line basis over the balance period of lease.
The residual values are not more than 5% of the original cost of the asset.
The assets' residual values and useful lives are reviewed, and adiusted if appropriate, at the end of each reporting period. An
asset's carrying amount is written down immediately to its recoverable amount if the asset's carrying amount is greater than its
estimated recoverable amount.
c) Intangible assets
Intangible assets that are acquired by the Company are measured initially at cost. After initial recognition, an intangible asset is
carried at its cost less any accumulated amortization and accumulated impairment loss.
Subsequent expenditure is capitalized only when It increases the future economic benefits from the specific asset to which it
relates. An intangible asset 1s derecognized on disposal or when no future economic benefits are expected from its use and
disposal.
Losses arising from retirement and gains or losses arising from disposal of an Intangible asset are measured as the difference
between the net disposal proceeds and the carrying amount of the asset and are recognized in the statement of profit and loss.
t
~~ -
recove ~ amount, the asset is considered impaired and is written down to its recoverable amount.
IHMC: \ADJ
~DA.CVJ2
!{.
,.,+;'j~
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
CIN : L24231GJ1995PLC024809
In assessing value in use. the estimated future cash flows are discounted to their present value using a pre-tax discount rate that
reflects current market assessments of the time value of money and the risks specific to the asset. In determining fair value less
costs of disposal, recent market transactions are taken into account. If no such transactions can be identified, an appropriate
valuation model is used.
Impairment losses are recognized in the statement of profit and loss. After impairment, depreciation is provided on the revised
carrying amount of the asset over its remaining useful life.
When there is indication that an impairment loss recognised for an asset (other than a revalued asset) in earlier accounting
periods no longer exists or may have decreased, such reversal of impairment loss is recognised in the Statement of Profit and
Loss, to the extent the amount was previously charged to the Statement of Profit and Loss.
e) Financial Instruments
Financial assets and financial liabilities are recognised when a Company becomes a party to the contractual provisions of the
instruments.
Initial Recognition
Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the
acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value
through profit or loss and ancillary costs related to borrowings) are added to or deducted from the fair value of the fmanc1al
assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of
financial assets or financial liabilities at fair value through profit or loss are recognised immediately in Statement of Profit and
Loss.
l~ as 9 ;"'
(il RQ ncial Liabilities at FVTPL
£ . .~~~~ bilities are classified as at FVTPL when the financial liability is held for trading or are designated upon initial recognition
O' Losses on Uabilities held fo' t<ad;ng a<e 'ecogn;sed ;n the Si.tement of Prnfit and Loss.
PRAVEG COMMUNI CATIONS (INDIA} LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
CIN : L24231GJ1995PLC024809
Financial assets, other than those at FVTPL, are assessed for indicators of impairment at the end of each reporting period. The
Company recognises a loss allowance for expected credit losses on financial asset. In case of trade receivables, the Company
follows the simplified approach permitted by Ind AS 109 - Financial Instruments fo r recognition of impairment loss allowance. The
application of simplified approach does not require the Company to track changes in credit risk. The Company calculates the
expected credit losses on trade receivables using a provision matrix on the basis of its historical credi t loss experience.
On derecognition of a financial asset in its entirety, the difference between the asset's carrying amount and the sum of the
consideration received and receivable and the cumulative gain or loss that had been recognised in other comprehensive income
and accumulated in equity is recognised in profit or loss if such gain or loss would have otherwise been recognised in profit or loss
on disposal of that financial asset.
A financial liability is derecogn1zed when the obligation under the liabillty is discharged or cancelled or expires. When an existing
financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability
are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the
recognition of a new liability. The difference in the respective carrying amounts is recogni zed In the statement of profit or loss.
~#
PRAVEG COMMUNICATIONS (INDIA) LIMITED
{FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
CIN: L24231GJ199SPLC024809
Equity Instruments
An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities
Equity instruments issued by a Company are recognised at the proceeds received.
f) Taxes on Income
Current Income tax
Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation
authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the
reporting date In the countries where the company operates and generates taxable income.
Current income tax relating to items recognised outside profit or loss is recognised outside profit or loss (either in other
comprehensive income or in equity) Current tax items are recognised in correlation to the underlying transaction either in OCI or
directly in equity. Management periodically evaluates positions taken 1n the tax returns with respect to situations 1n wh1cl':
applicable tax regulations are subject to interpretation and establishes provisions where appropriate.
ii Deferred tax
Deferred income tax Is recognized using the balance sheet approach, deferred tax is recognized on temporary differences at the
balance sheet date between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes,
except when the deferred income tax arises from the initial recognition of goodwill or an asset or liability in a t ransaction that 1s
not a business combination and affects neither accounting nor taxable profit or loss at the time of the transaction
Deferred Income tax assets are re cognized for all deductible temporary differences, carry forward of unused tax credits and
unused tax losses, to the extent that It Is probable that taxable profit will be available against which the deductible temporary
differences. and the carry forward of unused tax credits and unused tax losses can be utilized.
The carrying amount of deferred Income tax assets is reviewed at each balance sheet date and reduced lo the extent that 1t is no
longer probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized
Deferred income tax assets and liabilities are measured al the tax ra tes that are expected to apply in the period when the asset is
realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the balance
sheet date.
Deferred tax assets and deferred tax liabilities are offset if a legally enforceable right exists to set off current tax assets against
current tax liabilities and the deferred taxes relate to the same taxable entity and the same tal\ation authoritv.
MAT payable for a year is charged to the statement of profit and loss as current tax. The Company recognizes MAT credil
available in the statement of profit and loss as deferred tax with a corresponding asser only to the extent that there 1s probability
that the Company will pay normal income tax during the specified period, i.e., the period for which MAT credit is allowed to be
carried forward. The said asset 1s shown as 'MAT Credit Entitlement' under Deferred Tax. The Company reviews the same at each
reporting date and writes down the asset to the extent the Company does not have probable certainty that It will pay normal tax
during the specified period.
g) Inventories
Inventories are valued at the lower of cost and net realisable value
Costs comprises cost of procurement, cost of conversions and other overheads directly attributable to bringing the invento11es to
its present locatfon and condit ion.
Net realisable value Is the estimated selling price in the ordinary course of business, less estimated costs of completion and the
estimated costs necessary to make the sale. The net realizable value of work-in-progress is determined with reference to the
selling prices of related finished products. Raw materials and other supplies held for use in production of finished products are not
written down below cost except in cases where material prices have declined and it is estimated that the cost of the f1n1shed
products will exceed their net realizable value.
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
CIN: L24231GJ1995PLC024809
h) Revenue recognition
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can
be reliably measured, regard less of when the paym ent is being made. Revenue from contracts with customers for sale of Goods
or Services is recognized wh en either at a point In time or over time, when (or as) the Company satisfies performance obligations
by transferring the promised goods or service to its customers and there is a certainty of collection of revenue. The Company
collects GST on behalf of the Government and, therefore, these are not economic benefits flowing to the Company. Hence, they
are excluded from revenue. Revenue is disclosed net of discounts, incentives and returns, as applicable.
Dividend is recognised when the company's right to receive the payment is established, which is generally when shareholders
approve the dividend.
i) Employee benefits
(i) Short- term obligations
Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after
the end of the period in which the employees render the related service are recognised in respect of employees' services up to
the end of the reporting period and are measured at the amounts expected to be paid when the liabilities are settled. The
liabilities are presented as current employee benefit obligations in the balance sheet.
The liabilities for earned leave and sick leave are expected to be settled wholly within 12 months after the end of the period in
which the employees render the related service. They are therefore measured at expected payments to be made in respect of
services provided by employees.
The company operates defined contribution plans viz provident fund and pension plans as a part of its post-employment schemes.
The company pays provident fund contributions to pubhcly administered provident funds as per local regulations. The company
has no furt her payment obligations once the contributions have been paid. The contributions are accounted for as defined
contribution plans and the contributions are recognised as employee benefit expense when they are due. Prepaid contributions
are recognised as an asset to the extent that a cash refund or a reduction in the future payments is available.
j) Leases
The determination of whether an arrangement is (or contains) a lease is based on the substance of the arrangement at the
inception of the lease. The arrangement is, or contains, a lease if fulfilment of the arrangement is dependent on the use of a
specific asset or assets and the arrangement conveys a right to use the asset or assets, even if that righ t is not explicitly specified
in an arrangement.
As a lessee
A lease is classified at the inception date as a finance lease or an operatin g lease. Leases of property, plant and equipment where
the company, as lessee, has substantially all the risks and rewards of ow nership are classified as finance leases.
Leases in which a significant portion of the risks and rewards of ownership are not transferred to the company as lessee are
classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the
period of the lease unless the payments are structured to increase in line with expected general inflation to compensate for the
lessor's expected inflationary cost increases. Land leases for long term (say, 99 years) are classified as finance leases and not
depreciated.
As a lessor
Leases are classified as finance leases when substantially all of the risks and rewards of ownership transfer from the Company to
the lessee. Amounts due from lessees under finan ce leases are recorded as receivables at the Company's net investment in the
1
16<},~inan ce lease income is allocated to accounting periods so as to reflect a constant periodic rate of return on the net
~/ 1f19eftete~t outstan ding in respect of the lease.
~~·· . ~
PRAVEG COMMUNICATIONS (INDIA) LIMITED
{FORMERLY KNOWN AS SWORD ANO SHIELD PHARMA LIMITED)
CIN : L24231GJ 199SPLC024809
Lease income from operating leases where the company Is a lessor is recognised in income on a straight-line basis over the lease
term unless the receipts are structured to increase in line with expected general inflation to compensate for the expected
inflationary cost increases. The respective leased assets are included in the balance sheet based on their nature.
If t he effect of t he t ime value of money is material, provisions are determined by discounting the expected future cash flows to
net present value using an appropriate pre-tax discount rate that reflects current market assessments of the time value of money
and, where appropriate, the risks specific to the liability. Unwinding of the discount is recognised in the Statement of Profit and
Loss as a finance cost. Provisions are reviewed at each reporting date and are adjusted to reflect the current best estimate.
A present obligation that arises from past events where It is either not probable that an outflow of resources will be required to
settle or a reliable estimate of the amount cannot be made, is disclosed as a contingent liability. Contingent liabilities are also
disclosed when there is a possible obligation arising from past events, the existence of which will be confirmed only by the
occurrence or non -occurrence of one or more uncertain future events not wholly within the control of the Company.
Claims against the Company where the possibility of any outflow of resources In settlement is remote, are not disclosed as
contingent liabilities.
Contingent assets are not recognised in financial statements since this may result in the recognition of income that may never be
realised. However, when the realisation of income is virtually certain, then the related asset is not a contingent asset and is
recognised.
l) Borrowing costs
Borrowing costs are interest and other costs that the Company incurs in connection with the borrowing of funds and is measured
with 1efe1 ence to the effective interest rate (EIR) applicable to the respective borrowing. Borrowing costs include Interest costs
measured at EIR and e)(change differences ari sing from foreign currency borrow ings to the extent they are regarded as an
adjustment to the interest cost.
Borrowing costs, allocated to qualifying assets, pertaining to the period from commencement of activities relating to construction
Idevelopment of the qualifying asset up to the date of capitalisation of such asset are added to the cost of the assets.
Capitalisation of borrowing costs is suspended and charged to the Statement of Profit and Loss during extended periods when
active development activity on the qualifying assets is interrupted.
All other borrowing costs are recognised as an expense in the period which they are incurred.
-the after income tax effect of interest and other financing costs associated with dilutive potential equity
*': ,.thewe/ghted average number of additional equity shares that would have been outstanding assuming the conversion of
l::Jr~ all dilu) ll: rtential equity shares.
~" _.:;J
PRAVEG COMMUNICATIONS (I NDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
CIN: L24231GJ1995PLC024809
o) Cash and cash equivalents
Cash and cash equivalent in the balance sheet comprise cash at banks and on hand and short-term deposits with an original
maturity of three months or less, which are subject to an Insignificant risk of changes in value.
For the purpose of the statement of cash flows, cash and cash equivalents consist of cash and short-term deposits, as defined
above, net of outstanding bank overdrafts as they are considered an integral part of the Company's cash management.
r) Government Grants
Government grants whose primary condition is that the Company should purchase, construct or otherwise acquire non-current
assets are recognised as deferred revenue in the balance sheet and transferred to profit or loss in the period in which they
become receivable.
s) Dividends
Provision ls made for the amount of any dividend declared, being appropriately authorised and no longer at the discretion of the
entity, on or before the end of the reporting period but not distributed at the end of the reporting period.
The Company assesses, at each reporting date, whether there is an indication that an asset may be impaired. If any indication
exists, or when annual impairment testing for an asset is required, the Company estimates the asset's recoverable amount. An
asset's recoverable amount is the higher of an asset's or cash-generating unit's {CGU) fair value less costs of disposal and its value
in use. Recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that are largely
Independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its
recoverable amount, the asset is considered impaired and is written down to its recoverable amount.
In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that
reflects current market assessments of the time value of money and the risks specific to the asset. In determining fair value less
costs of disposal, recent market transactions are taken into account. If no such transactions can be identified, an appropriate
valuation model is used.
iv Recoverability of trade receivables
In case of trade receivables, the Company follows the simplified approach permitted by Ind AS 109 - Financial Instruments for
recognition of impairment loss allowance. The application of simplified approach does not require the Company to track changes
in credit risk. The Company calculates the expected credit losses on trade receivables using a provision matrix on the basis of its
historical credit loss experience.
v Useful lives of property, plant and equipment/intangible assets
The Company reviews the useful life of property, plant and equipment/intangible assets at the end of each reporting period. This
reassessment may result in change in depreciation expense in future periods.
vi Taxes and valuation of deferred tax assets
Significant management judgement is required to determine the amounts of current taxes, deferred taxes and tax credits that can
be recognised, based upon the likely timing and the level of future taxable profits together w ith future tax planning strategies.
The Company reviews the carrying amount of deferred tax assets at the end of each reportin g period. The policy for the same has
been explained under policies above.
vii Defined benefit plans
The cost of the defined benefit gratuity plan and other post-employment medical benefits and the present value of the gratuity
obligation are determined using actuarial valuations. An actuarial valuation involves making various assumptions that may differ
from actual developments in the future. These include the determination of the discount rate, future salary increases and
mortality rates. Due to the complexities involved in the valuation and its long-term nature, a defined benefit obligation 1s highly
sensitive to changes in these assumptions. All assumptions are reviewed at each reporting date.
viii Impairment of investments in associates
Determining whether investment in associate is impaired requires an estimation of the value in use of the investee entity. The
value in use calculation requires management to estimate the future cash flows expected to arise from the associate's operations
and a suitable discount rate in order to calculate present value.
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
Notes to the Standalone Financial Statements for the year ended on 31-03-2020
Cost
As at 1-4-2018 1.38 93.02 59.88 6.33 62.98 45.24 268.83 1.37
Addit ions 0.00 0.00 S43 0.00 194.45 4.29 204.17 0.00
Disposals/ Ad1ustments 0.00 0.00 000 0.00 0.00 0.00 0.00 0.00
As at 31·3-2019 1.38 93.02 65.31 6.33 257.43 49.53 473.00 1.37
Accumulated Degreciation
As at 1-4-2018 0.00 25.69 26.47 5.67 52.77 37.06 147.66 0.64
Depreciation charge for the year 0.00 6.40 6.78 0.14 22.55 3.76 39.63 0.37
Disposals/ Adjustments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
As at 31-3-2019 0.00 32.09 33.25 5.81 75.32 40.82 187.29 1.01
~
Vehic held in the name of Directors on behalf of the company.
~ !Ci umber:- 40 for note on amalgamation.
~·
~~'
~"9fn Ar.C,~ ~
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD ANO SHIELD PHARMA LIMITED)
Notes to the Standalone Financial Statements for the year ended on 31-03-2020
Materials for Events & Exhibitions (lower of cost and net realisable value) 244.28 195.76
6.1 Materials for Events & Exhibitions are hypothecated to bank against working capital facilities (Refer note 17.2)
6.2 Refer note number :- 40 for note on amalgamation.
As at As at
Particulars
31-Mar-2020 31-Mar-2019
7.1 Fair value of trade receivables is not materially different from carrying value presented.
7.2 Trade receivables are hypothecated to bank against working capital facilities. (Refer note 17.2)
7.3 The Company ls having majority of receivables from Government Companies, Local Authorities and Departments of
State/Central Government and regularly receiving dues from its customers. Hence, credit losses In the future are not material.
Out of all Trndc Receivables 86.34 % are receivables from such Government Companies, Locdl Aulhorities and Departments of
State/Central Government. Company regularly receives money receivable, reducing the credit risk Loss.
As at As at
Particulars
31-Mar-2020 31-Mar-2019
9 .1 Fair value of Other Bank Balance is not materially different from the carrying value presented.
9 .2 These fixed deposits are not available for immediate use being in the nature of security offered and held for guarantee
9 .3 Refer note number :- 40 for note on amalgamation.
10.1 Fair value of Current loans is not materially different from the carrying value presented.
10.2 Refer note number;- 40 for note on amalgamation.
10.3 Refer note number :- 39 for realted party transactions.
10.4 Refer note number:- 38 for Un hedged forex exposure
Notes to the Standalone Financial Statements for the year ended on 31-03-2020
13 Equ ity Share Capital Amount In Rs. m Lokhs Except number of shores
As at As at
Particulars
31-Mar-2020 31-Ma r-2019
1,850.00 600.00
Issued, Subscribed and fully Paid Up Capital
1,84,84,100 Equity Shares of Rs.10/ - each fu lly paid up 1,848.41 515.06
Previous Year: 51,50,600 Equity Shares of Rs.10/- each fu lly paid up
1,33,33,500 Equity share of Rs. 10/- each fully paid up pending for issue 0.00 1,333.35
13.3 Reconciliation of the shares outstanding at the beginning and at the end of the reporting year
As at As at
3 l -M ar-2020 31-Mar-2019
Equity Shares
No. Shares Amount in Rs. in No. Shares Amount in Rs. in
Lakhs Lakhs
At the beginning of the Year -Fully Paid Up 51,50,600 515.06 51,50,600 515.06
Add : Addition during the year in pursuant to
1,33,33,500 1,333.35 0 0.00
scheme of arrangement
13.4 Details of shareholders holding with voting power more than 5% Equity shares in the Company
As at As at
31-Mar-2020 31-Mar-2019
Name of Share holders
No. Shares % holding in the No. Shares % holding in the
class class
I . ~.1~1)
1,19,92,275 64.88 0
:p ;
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIM ITED)
Notes to the Standa lone Financial Stateme nts for the year ended on 31-03-2020
Particulars
As at As at
31-Mar-2020 31-Mar-2019
Retained Earnings
Opening Balance 545.85 (495.94)
Add: Additions pursuant to the scheme of arrangement during the year 0.00 767.57
Add : Profit I (Loss) for the period 364.45 286.42
910.30 558.05
Less : Dividend Paid • 35.56 10.14
Dividend Distribution Tax** 7.30 2.06
Tax on Buy Back of Equity*** 6.85 0.00
(Refer note number 14.2) 49.71 12.20
Closing Balance 860.59 545.85
General Reserve
Opening Balance 57.77 0.00
Add: Additions pursuant to the scheme of arrangement during the year 0.00 57.77
Less: Utilised I transferred during the year 0.00 0.00
Closing Balance 57.77 57.77
Share Premium Reserve
Opening Balance 37.63 0.00
Add: Additions pursuant to the scheme of arrangement during the year 0 .00 169.56
Less: Utilised I transferred during the year (Refer note 14.2) **** 0.00 131.93
Closing Balance 37.63 37.63
Capital Reserve
Opening Balance (1,315.57) 0.00
Add: Additions pursuant to the scheme of arrangement during the year 0.00 (1,315.57)
Less: Utilised/ transferred during the year 0.00 0.00
Closing Balance (1,315.57) (1,315.57)
53.14 95.29
38.69 0.00
91.83 95.29
PRAVEG COM MUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
Notes to the Sta ndalone Financial Statements for the year ended on 31-03-2020
Notes:
15.1 Security Details for the Balance as at 31-03-2020:
Term Loans from banks and other referred are secured by hypothecation of vehicles.
As at As at
Particula rs
31- Mar-2020 31-Mar-2019
As at As at
Particulars
31-Mar-2020 31-Mar-2019
d Directors including promoter Sunita Patel has given Personal Guarantee for the Cash Credit Loan to Company.
17.3 Unsecured Borrowing from Bank includes balances of Credit Cards.
17.4 Fair value of current borrowings is not materially different from the carrying value presented.
18.l Fair value of other Trade Payables is not materially different from the carrying value presented.
18.2 Refer note number :- 40 for note on amalgamation.
18.3 The information required to be furnished as per Section 22 of the Micro, Small and Medium Enterprises Development Act, 2006
(MSMED Act) and Schedule Ill of the Companies Act, 2013 for the year ended March 31, 2020 has been determined to the
extent such parties have been identified on the basis of information available with the Company and relied upon by auditors.
19.1 For security and other details related to secured other current Financial Liabilities refer note number :- 15
19.2 Refer note number:- 40 for note on amalgamation.
44.21 5.87
44.21 5.87
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
Notes to the Standalone Financial Statements for the year ended on 31-03-2020
Interest income
Interest income on financial assets 9.24 11.62
606.05 685.48
PRAVEG COMM UNICATIONS (IN DIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIM ITED)
Notes to t he Standa lo n e Fina n cia l Stateme nts for the yea r ended o n 31-M arch-2020
Payments to the auditors comprises (net of GST input credit, where applicable):
For statutory audit 6.00 2.00
For other services 0.00 0.00
Total 6.00 2.00
30 Segment Disclosure
The activities of Erstwhile Praveg Communications Limited (transferor Company) during the year was to origination of Events,
Exhibitions, Advertisement and Hospitality. The activities of Praveg Communications (India) Limited (formerly knowns as Sword and
Shield Pharma Limited) during the year was business of commission on pharma related products. Considering the nature of business and
operation post-amalgamation, as well as based on reviews of operating results by chief operating decision maker to make decision about
resource allocation and performances measurement. there is only one reporting segment in accordance with the requirement of Ind As -
108 - "Operating Segments".
31 Employee Benefit s
The Company's contribution to Provident Fund aggregating~ 5.49 lakhs (in Previous Year 2018-19 : ~ 3.82 lakhs) has been recognised in
the Statement of Profit and Loss under the head Employee Benefits Expense.
T he status of g ratuity plan as required under Ind AS-19 is as follow s:- Amountin Rs in lakhs
As at
Particulars
31-03-2020
ii. Reconci liation of Opening and Closing Balances of the Fair valueof Plan assets
Fair Value of Plan Assets at the Beginning of the Period 0.00
Contributions by the Employer 0.00
Assets Transferred In/Acquisitions 0.00
Fair Value of Plan Assets at the End of the Period 0.00
PRAVEG COMMUNICATIONS (INDIA} LIM ITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
Notes to the Standalone Financial Statements for the year ended on 31-March-2020
As at
Particula rs
31-03-2020
lii. Reconciliation of the Present value of defined benefit obligation and Fair va lue of plan assets
Present Value of Defined Benefit Obligations at the end of the year 24.08
Fair Value of Plan assets at the end of the year 0.00
Net (liability)/Assets recognized in balance sheet as at the end of the year (24.08)
Short-term provision (2.08)
Long-term provision (22.00)
v. Actuarial Assumptions
Expected Return on Plan Assets N.A.
Rate of Discounting 6.87%
Rate of Salary Increase 6.00%
Rate of Employee Turnover 5.00%
a) The sensitivity analysis have been determined based on reasonably possible changes of the respective assumptions occurring at the
end of the reporting period, while holding all other assumptions constant.
b) The sensitivity analysis presented above may not be representative of the actual change in the projected benefit obligation as it 1s
unlikely that the change in assumptions would occur in isolation of one another as some of the assumptions may be correlated.
c ~ in presenting the above sensitivity analysis, the present value of the projected benefit obligation has been calculated
l 8~ng e jected unit credit method at the end of the reporting period, which is the same m ethod as applied in calculating the
u ~· projecte e efit obligation as recognised in the Balance Sheet.
ri • ') l
q "" _;.: ' -
K!
PRAVEG COMMUN ICATIONS (IN DIA) LI M ITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
N otes to the Standa lone Financia l Statements for the year e n ded on 3 1- March-2020
As at
Pa rt ic ulars
3 1-03- 2020
32 Basic/Diluted Earnings per Equlty share ( EPS) Amount In Rs. m Lok/ls Except no. of shore
As at As at
Partic ulars
31- Ma r-2020 31-M ar-2019
Ea rnings per e quity share
Profit attributable to equity shareholders 364.45 286.42
Weighted average number of equity shares outstanding during the year 18484100 18484100
Nominal value of equi ty share 10.00 10.00
Basic and Diluted EPS 1.97 1.55
32. l Weighted average number of equity share outstanding during the FY 2018-19 includes 1,33,33,500 equity Shares pending for issue
pursuant to amalgamation scheme.
32.2 Earning Per Share is not computed as per Ind AS 33 with respect to issue of Amalgamation, since the company has followed
accounting treatmen t specified under scheme approved by Hon'ble NCL T.
33 Contingent liabilities
Amount m Rs. in Lok/ls
As at As at
Partic ulars
31- M ar-2020 31- M ar- 2019
i) Claim of demand against the Company not acknowledged as debt in
respect of -
a) Service Tax 212.85 0.00
ii) Counter Guarantees
a) Outstanding amount of Counter Bank Guarantees 217.45 263.18
33. 1 Company has received unfavourable orders from Commissioner of Central Goods and Service Tax, & Central Excise by which a
demand of Rs.106.38 lakhs has been raised and Penalty there on of Rs. 106.38 lakhs has been imposed under section 78 of the
Finance Act, 1994 and Rs. 0.10 lakhs under Section 77(2) of the Finance Act, 1994, with interest recoverable under Section 75 of the
Finance Act, 1994, against which the Company is proposing to file an appeals before its higher authority being
Commissioner(Appeals), Central GST & Central Excise .. The Management 1s of the view that in view of facts of the case, no liability
shall arise with respect to above litigations.
33.2 Above Contingent Liabilities of service Tax, Rs. 212.85 Lakh s Includes Penallty of 106.48 Lakhs based order dated 03-06-2020 i.e.
event occuring after Balance Sheet Date.
In view of t he amalgamation of Praveg Communications Limited with Praveg Communications (India) Limited (Formerly known as
Sword and Shield Pharm a Limite d), the financial results given for previous year includes fi nancials of t ransferor company
lncor orated w ith that of resulting company as a better comparisons for the rea ders of the financial statements.
·~~
~,,,statements have been approved by the Board of Directors of Company on 3-7-2020.
~~ ,,.,r 1 ~
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD ANO SHIELD PHARMA LIMITED)
Notes to the Standalone Financial Statements for the year ended on 31-March-2020
Financial liabilities
i Borrowings 0.00 0.00 91.83 91.83
ii Current Borrowings 0.00 0.00 3.48 3.48
iii Trade payables 0.00 0.00 512.94 512.94
iv Ot her financial liabilities 0.00 0.00 93.93 93.93
Tot al 0.00 0.00 702.18 702.18
Amount as at 31-3-2019
Fair Value Fair Value Amortised Cost Total
Particulars through through Other
Profit & Loss Comprehensive
Income
Financial assets
i Trade receivables 0.00 0.00 782.47 782.47
ii Cash and cash equivalents 0.00 0.00 95.55 95.55
iii Bank balance other than (ii) above 0.00 0.00 103.53 103.53
iv Current Loans 0.00 0.00 549.20 549.20
v Other financial assets 0.00 0.00 18.78 18.78
Total 0.00 0.00 1,549.53 1,549.53
Financial liabilities
i Borrowings 0.00 0.00 95.29 95.29
ii Cu rrent Borrowings 0.00 0.00 416.32 416.32
iii Trade payables 0.00 0.00 303.88 303.88
iv Other financial liabilities 0.00 0.00 48.20 48.20
Total 0.00 0.00 863.69 863.69
B. Capital Management
For the purpose of the Group's capital management, capital includes issued equity capital and all other equity reserves attributable
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SH IELD PHARMA LIMITED)
Notes to the Standalone Financial St at ements for the year ended on 31-March-2020
ii Consistent with others in the Industry, the Group monitors Its capital using Gearing Ratio, Net Debt (Short Term and Long Term
Borrowings including Current maturities) divided by Total Capital (Total Equity plus Net Debt).
Amount m Rs. in lokhs
As At As At
Particulars
31-Mar-20 31-Mar-19
Long Term Borrowings 91.83 95.29
Short Term Borrowings 97.41 464.52
Less: Cash & Cash Equivalents 252.22 95.55
Net Debt (62.98) 464.26
Total equity 1,488.83 1,174.09
Total Capital 1,678.07 1,733.90
Gearing Ratio(%) (3.75) 26.78
iii In order to achieve this overall objective, the Group's capital management, amongst other things, aims to ensure that it meets
financial covenants attached to the borrowings that define the capital structure requirements.
Foreign currency risk 1s the nsk that the tair value or tuture cash tlows ot an exposure will tluctuate because ot cnanges in tore1gn
exchange rates. The Group does not have significant exposure in foreign currency. The Group is mainly exposed to changes in USO
and AUD. The below table demonstrates the sensitivity to a 1% Increase or decrease rn the USO or AUD rates against INR, with all
other variables held constant. The sensitivity analysis is prepared on the net unhedged exposure of the Group as at the reporting
daJ o represen ts management's assessment of reasonably possible change in foreign exchange rate.
~i'"Lcr
~~ ~<?
* All
~
~
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SH IELD PHARMA LIMITED)
Notes to the Standalone Financial Statements for the year ended on 31-March-2020
Amount in Rs in Lokhs
Impact on Profit before tax Impact on Profit after tax
Particulars for the year ended for the year ended
31-Mar-20 31-Mar-19 31-Mar-20 31-Mar-19
Impact on the profit for 1% appreciation I
depreciation in exchange rate between the Indian 1.22 5.27 0.91 3.80
Rupee and USO.
Impact on the profit for 1% appreciation I
depreciation in exchange rate between the Indian 0.02 0.02 0.01 0.01
Rupee and AUD.
2 Liquidity Risk
I he t:iroup monitors its risk or a shortage ot tunds by estimating the ruture cash trows. r he <:iroup·s OOJect1ve 1s to maintain a
balance between continuity of funding and flexibility through the use of bank overdrafts, cash credit facilities and bank loans. The
Group has access to a sufficient variety of sources of funding
The table below summarises the maturity profile of the Group's financial liabilities based on contractual undiscounted payments.
Amount as at 31-3-2019
Particulars W1th1n 1to5 More than
Total
1 Year Year 5 Year
Borrowings 464.52 95.29 0.00 559.81
Trade Payables 303.88 0.00 0.00 303.88
Total 768.40 95.29 0.00 863.69
The above tables do not include liability on account of future interest obligations.
3 Credit Risk
Credit risk is the risk that counterparty will not meet its obligations under a financial instrument or customer contract, leading to a
financial loss. The Group is having majority of the receivables from Government Authorities, companies, or local authorities and
hence, credit losses in the future are not material.
37 Movement in Deferred Tax Assets I Liabilities for the year ended 31-March-2020
Amount in Rs in Lokhs
Movement during the year ended on 31-3-2019
Tax effects of items constituting Recognised in
Recognised
Opening balance other Closing balance as
Deferred tax liabilities/ assets in profit and
as at 1-4-2018 comprehensive at 31-3-2019
loss
income
Property, plant and equipment 14.38 1.63 0.00 16.01
A Income tax (income) I expense recognized in the Statement of Profit and Loss
Amount in Rs in lokhs
For t he Year Ended For the Year Ended
Particulars
31-03-2020 31-03-2019
Current Tax
Current tax on profit for the year 156.30 116.00
(Excess) I Short provision of earlier periods 0.42 (0.26)
Sub Total 156.72 115.74
Deferred Tax
Deferred Tax (Other than MAT Entitlement) (0.20) (1.63)
The details of foreign currency exposure not hedged are as under Amount In Rs. In Lokhs
As at 31-3-2020 As at 31-3-2019
Sr. No. Particulars
Amount (INR) Foreign Currency Amount (INR) Foreign Currency
1 Loan to Subsidiaries 122.13 1,62,000 $ 527.09 7,62,000 $
2 Loan to Subsidiaries 1.85 4000 AUD 1.98 4000AUD
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SH IELD PHARMA LIMITED)
Notes to the Standalone Financial Statements for the year ended on 31- March-2020
Non-Executive Directors
Subsidiaries
Joint Venture
The scheme provided that accounting for giving effect to the Scheme of Amalgamation shall be as per the Pooling of Interest
method prescribed under Accounting Standard - 14 'Accounting for Amalgamation' prescribed under the Companies (Accounting
Standard) Ru les, 2006 as amended from time to time. Accordingly, the transferee company has recorded all the assets and l1ab1l1t1es
of the transferor company 1n its books in the same form and manner as 1t appeared 1n the books of transferor company on the
Appointed Date. Inter-company balances, if any, have been adiusted.
PRAVEG COMMUNICATIONS (INDIA) LIMITED
(FORMERLY KNOWN AS SWORD AND SHIELD PHARMA LIMITED)
Notes to the Standalone Financial Statements for the year ended on 31-March-2020
Erstwhile Praveg Communication Ltd ( Transferor Company) had the following Balances as on date specified.
... . .... . .... . . ... . . . .... . . .... . . . . . . ... . . . ... . . . . ... . . . . . . . . .... . . . . . . .!. . . . . . . . . . . . . !. . . ... . . . . . . . . .
Equity
Equity Share Capital 17.78 17.78
............................................................................................................................................................................................................................... 17.78
........................................
Other Equity 1,461.20 1,145.61 634.04
............................................................................................................................................................................................................................... ........................................
!. . . . . . . . . . . . . .!. . . . . . . . . . . . .
Non-current Liabilities
.~~~.?.~.~~~!Y~~~!.i~~~.~.................................................................................................................................................
-Non-current Borrowings 91.82 95.29 169.75
......................................................................................................................................................................................................................................................................
.~?.~~..!.~.~.~.~~?~.1.~.i.?.~~ .................................................................................................... ............................~~:.??. . ..............................9.:9.? ..............................?.:?.?..
Current Liabilities
.~!0.?.~.~~~!..~~~.~!!!~!~.~................................................................................................................................................................................................................................
..... ~~.~r.~.~~.~. ~?.~.~?.':'!.!.~~.~................................................................................................................................~...~~..........................~.~~:~.~ ..........................~.?.?.:~.~
..... ~!.r.~?.~..~~.Y.?.~.~~.~ ........................................................................................................... .........................:..~~:.?..~ .... ...................... ~.??:~.?. ......................... ~.?..~:~.:.
-Other Financial Liabilities 93.93 48.20 0.00
As per the scheme, the business of the transferor company shall be deemed to have been carried on by the transferor company for
and on behalf of the transferee company. Accordingly the resu lts of profit from the appointed date to effective date amounting to
Rs. 288.32 Lakhs has been adjusted to the Profit and Loss Account as on 01-04-2018.
The transferee Company prepares and presents its financial statements as per the Indian Accounting Standards prescribed under
section 133 of the Companies Act, 2013 and accordingly the income, expenses, assets and liabilities have been recognised,
measured and presented as per the Indian Accounting Standard.
41 Impact of Covid-19
The Outbreak of Coronavirus (COVID-19) pandemic globally and in India is causing significant disturbance and slowdown of
economic activities. Measures taken to contain the spread of the virus, Including travel bans, quarantines, social distancing, and
closures of non-essential services have triggered significant disruptions to businesses worldwide, resulting in an economic
slowdown. Holding of events and exhibitions being undertaken by the Company had been temporarily suspended during
nationwide lockdown. Business operations have been resumed in a phased manner in line with directives from the authorities
The Company has considered internal and external sources of information up to the date of approval of these standalone financia l
results, In assessing the recoverability of its trade receivables, inventories, investments in and loans given to subsidiaries, liquidity,
financial position and operations of the Company and based on the management's assessment, there 1s no material impact on the
standalone financial affairs of the Company.
Considering the uncertainties involved in estimating the impact of this force majure pandemic situation, the future impact of this
pandemic may be different from those estimated as on the date of approval of these financial affairs.
~<
- -\ ~ishnukumar Pat el
Managing Director Chairman
Pa DIN :- 00467608 DIN :- 02011649
At _Q~
Membership No.039919
Mukesh Chaudhary
Chief Financial Officer Company Secretary